C-type virus-associated antigens and their relevance to human leukemia control
- PMID: 56221
C-type virus-associated antigens and their relevance to human leukemia control
Abstract
This review describes oncogenic C-type virus and virus-associated antigens as phenotypic expressions of virus activities in malignant cells and cell surface antigens acquired by malignant transformation. The range of host-immune responses to these antigens in experimental systems is discussed in relation to the immunotherapy and immunoprophylaxis of human cancer patients.
Similar articles
-
Demonstration of different glycosylated antigens in C-type virus-transformed and infected rat cells by antiserum to murine leukemia virus.Cancer Res. 1977 Apr;37(4):1165-9. Cancer Res. 1977. PMID: 191179
-
Potential leukemia virus subunit vaccines: discussion.Cancer Res. 1976 Feb;36(2 pt 2):655-6. Cancer Res. 1976. PMID: 1253151 No abstract available.
-
Synthesis of a viral protein with molecular weight of 30,000 (p30) by leukemic cells and antibodies cross-reacting with Simian sarcoma virus p30 in serum of a chronic myeloid leukemia patient.Cancer Res. 1982 Feb;42(2):681-6. Cancer Res. 1982. PMID: 6173117
-
Immunotherapy of human leukemia.Mt Sinai J Med. 1972 Nov-Dec;39(6):548-65. Mt Sinai J Med. 1972. PMID: 4565179 Review. No abstract available.
-
Feline virus-induced tumors and the immune response: recent developments.Am J Vet Res. 1973 Jun;34(6):809-12. Am J Vet Res. 1973. PMID: 4350543 Review. No abstract available.